Kidney Organoid Derived from Human Pluripotent and Adult Stem Cells for Disease Modeling

Hyun Mi Kang1,2

  • 1Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea.

PubMed

Insights

Human kidney organoids derived from stem cells offer promising models for studying kidney diseases and cancer. These advanced in vitro models aid in understanding genetic kidney conditions and developing targeted therapies.

Area of Science:

  • Nephrology
  • Stem Cell Biology
  • Developmental Biology

Background:

  • Kidney disease impacts a large global population, with limited effective therapies due to a lack of accurate in vitro models.
  • Genetic discoveries in kidney disease have not translated into targeted treatments because of inadequate human disease models.
  • Human induced pluripotent stem cells (PSCs) offer a novel platform for disease modeling and drug validation.

Purpose of the Study:

  • To review the potential of human stem cell-derived kidney organoids for modeling genetic kidney diseases.
  • To explore the application of kidney organoids in understanding renal cancer.
  • To highlight the importance of structural and functional fidelity in kidney organoids for therapeutic development.

Main Methods:

  • Utilizing human induced pluripotent stem cells (PSCs) to generate kidney organoids.
  • Employing adult kidney stem cells for organoid development.
  • Reviewing existing literature on kidney organoid applications in disease modeling.

Main Results:

  • Human PSC-derived kidney organoids can recapitulate aspects of kidney development and disease.
  • These organoids show promise for in vitro drug screening and validation.
  • The structural and functional resemblance of organoids to adult kidneys is critical for their utility.

Conclusions:

  • Kidney organoids represent a significant advancement in modeling human kidney diseases, including genetic disorders.
  • These models are valuable tools for investigating renal cancer mechanisms.
  • Further development of kidney organoids is essential for accelerating the discovery of novel therapeutics for kidney ailments.